Back

Nationwide 5-year outcomes in U.S. dialysis patients with failed bioprosthetic surgical AVR: valve-in-valve TAVR versus redo surgery

31 August 2026 (13:55 - 14:05)
Organised by: Logo
Congress Presentation Part of: Advanced cardiorenal disease in clinical practice: implementation, interventions, and prognosis Renal Failure and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marco Tagliafierro

Columbia University, New York (United States of America)

5 More presentations in this session

Presentation thumbnail
Cardiorenal syndrome in German primary care: real-world diagnostics and SGLT2 Inhibitor use
Associate Professor S. Wassmann (Munich, DE)
Abstract
Presentation thumbnail
PEN2 stabilizes SLC25A51 to inhibit vascular calcification through NAD+ redistribution between mitochondrion and nucleus
Assistant Professor B. Dong (CN)
Abstract
Presentation thumbnail
Effects on albuminuria and blood pressure after radiofrequency renal denervation: two-year results from the Global SYMPLICITY Registry DEFINE
Professor M. Schlaich (Perth, AU)
Abstract
Presentation thumbnail
Association of the non–lipoprotein(a) apolipoprotein b–to–lipoprotein(a) ratio with renal dysfunction in cardiovascular disease patients: implications for atherosclerotic burden and prognosis
Doctor K. Yamamoto (JP)
Abstract
Presentation thumbnail
Clinical profile and determinants of NECPAL positivity in advanced cardiorenal syndrome: a prospective multicentre study
Doctor I. Navarro-Pelayo Torres (Granada, ES)
Abstract

Access the full session

Session thumbnail
Advanced cardiorenal disease in clinical practice: implementation, interventions, and prognosis

The Event

Event poster

ESC Congress 2026

31 August 2026 13:55 CET
You may be interested in
thumbnail
Congress Presentation
5-year outcomes of patients with mitral structural valve deterioration treated with transcatheter valve in valve implantation
26 August 2022
thumbnail
Congress Presentation
Mortality after implantable cardioverter defibrillators in dialysis patients: a nationwide study
1 September 2020
thumbnail
Congress Presentation
A single-centre perspective on survival and complications after transcatheter aortic valve replacement in chronic kidney disease and end-stage renal disease patients
19 May 2025
thumbnail
Congress Presentation
Contemporary trends and outcomes of percutaneous vs. surgical aortic valve replacement in cancer patients.
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources